ArticleBMC genomics2026
BiGKbhb: a bi-directional gated recurrent unit model for predicting lysine β-hydroxybutyrylation sites.
Article in BMC genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Post-Translational Modifications (PTMs) are covalent chemical alterations that occur after protein synthesis, critically regulating protein function, localization, and interactions. β-hydroxybutyrylation (Kbhb), a metabolically derived histone modification discovered in 2016, influences gene activation and cellular metabolism. While accurate PTM site identification is essential for understanding protein regulation and disease mechanisms, experimental approaches face significant limitations, including low modification abundance, high cost, and limited proteome coverage. Kbhb remains computationally underexplored, with only three existing prediction tools exhibiting modest accuracy and limited cross-species applicability. To address this gap, we developed BiGKbhb, a deep learning framework that depends on Bidirectional Gated Recurrent Units (BiGRU). With BiGKbhb, we systematically evaluate seven protein sequence encoding strategies, and compare six deep learning architectures using datasets from human, mouse, and fungal species. Results demonstrated that BLOSUM62 evolutionary encoding combined with BiGRU architecture achieves optimal performance, with BiGKbhb consistently achieving higher accuracy than those of existing methods with test set accuracies of 0.824, 0.832, and 0.871 for human, mouse, and fungal balanced datasets, respectively, with corresponding Area Under Curve (AUC) values of 0.920, 0.902, and 0.945, while additional evaluation on imbalanced datasets confirmed model robustness under realistic conditions. Cross-species analysis revealed enhanced transferability of the general multi-species model, and statistical validation confirmed significant improvements over existing predictors (p < 0.05). These findings contribute a robust computational tool for Kbhb prediction and provide insights into sequence determinants of this important modification across evolutionarily diverse species.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.